Case number 2016-2707
Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | VANDA PHARMACEUTICALS INC. v. WEST-WARD PHARMACEUTICALS [OPINION] [precedential] (0) |
| Jan 16, 2020 | 97 | The petition for writ of certiorari, [18-817], filed on 12/27/2018, was Denied on 01/13/2020. [663590] [JAB] [Entered: 01/16/2020 07:47 AM] (1) |
| Dec 28, 2018 | 96 | Petition for writ of Certiorari filed on 12/27/2018, and placed on the docket 12/27/2018, in the Supreme Court of the United States. Supreme Court #: 18-817, Hikma Pharmaceuticals USA Inc., et al. v. Vanda Pharmaceuticals Inc. [574978] [JAB] [Entered: 12/28/2018 02:42 PM] (1) |
| Aug 21, 2018 | 95 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [544241] [16-2707, 16-2708] [JAB] [Entered: 08/21/2018 09:34 AM] (1) |
| Aug 14, 2018 | 94 | ORDER filed denying [74] petition for en banc rehearing filed by West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [542674] [JAB] [Entered: 08/14/2018 10:40 AM] (2) |
| Jul 19, 2018 | 93 | Amended Certificate of Interest for the Appellant Hikma Pharmaceuticals USA Inc.. Service: 07/19/2018 by email. [536995] [16-2707] [Kenneth Schuler] [Entered: 07/19/2018 12:28 PM] (3) |
| Jul 18, 2018 | 92 | ORDER filed granting motion to modify the official caption [91] filed by Appellant West-Ward Pharmaceuticals Corp. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [536744]--[Edited 07/18/2018 by JAB to update pdf] [JAB] [Entered: 07/18/2018 12:04 PM] (2) |
| Jul 17, 2018 | 91 | MOTION of Appellant West-Ward Pharmaceuticals Corp. to modify the official caption [Consent: unopposed]. Service: 07/17/2018 by email. [536478] [16-2707] --[Edited 07/17/2018 by CAB to correct party filer] [Kenneth Schuler] [Entered: 07/17/2018 12:19 PM] (9) |
| Jul 13, 2018 | 90 | 18 paper copies of the response [89] received from Appellee Vanda Pharmaceuticals Inc. [535718] [JAB] [Entered: 07/13/2018 11:08 AM] (0) |
| Jul 12, 2018 | 89 | RESPONSE of Appellee Vanda Pharmaceuticals Inc. to the petition [74] filed by Appellants West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp.. Service: 07/12/2018 by email, US mail. [535557] [16-2707] [Nicholas Groombridge] [Entered: 07/12/2018 04:36 PM] (25) |
| Jun 28, 2018 | 88 | The court invites a response from Appellee Vanda Pharmaceuticals Inc. to the petition for en banc rehearing filed by Appellants in 16-2707. The response is due on or before 07/12/2018. [532389] [JAB] [Entered: 06/28/2018 08:12 AM] (1) |
| Jun 27, 2018 | 87 | 18 paper copies of the amicus Brief [86] received from Amici Curiae Inventia Healthcare Pvt. Ltd. and Mylan Inc. [532205] [JAB] [Entered: 06/27/2018 10:12 AM] (0) |
| Jun 27, 2018 | 86 | AMICUS BRIEF FILED on Petition for Inventia Healthcare Pvt. Ltd. and Mylan Inc.[84]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [532154] [JAB] [Entered: 06/27/2018 08:28 AM] (18) |
| Jun 27, 2018 | 85 | ORDER filed granting motion leave to file amicus brief on en banc or rehearing petition [83]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [532153] [JAB] [Entered: 06/27/2018 08:25 AM] (2) |
| Jun 26, 2018 | 84 | TENDERED from Inventia Healthcare Pvt. Ltd. and Mylan Inc. Title: AMICUS CURIAE BRIEF. Service: 06/26/2018 by email. [532123] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 07:30 PM] (18) |
| Jun 26, 2018 | 83 | MOTION of Inventia Healthcare Pvt. Ltd. and Mylan Inc. for leave to file amicus brief in support of Defendants-Appellants on petition for en banc rehearing [74] [Consent: unopposed]. Service: 06/26/2018 by email. [532122] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 07:29 PM] (9) |
| Jun 26, 2018 | 82 | NOTICE OF REJECTION: The brief of Inventia Healthcare Pvt. Ltd. and Mylan Inc., Amicus curiae brief on petition [81], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by the Clerk of Court. [532091] [JAB] [Entered: 06/26/2018 04:12 PM] (1) |
| Jun 26, 2018 | 81 | TENDERED from Inventia Healthcare Pvt. Ltd. and Mylan Inc. Title: AMICUS CURIAE BRIEF. Service: 06/26/2018 by email. [532046] [16-2707] This document has been rejected. See Doc. No. [82]. [Douglass Hochstetler] [Entered: 06/26/2018 02:37 PM] (0) |
| Jun 26, 2018 | 80 | Entry of appearance for Steven Yovits as of counsel for Inventia Healthcare Pvt. Ltd. and Mylan Inc.. Service: 06/26/2018 by email. [532043] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 02:31 PM] (2) |
| Jun 26, 2018 | 79 | Entry of appearance for Sarita Mutha as of counsel for Inventia Healthcare Pvt. Ltd. and Mylan Inc.. Service: 06/26/2018 by email. [532041] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 02:30 PM] (2) |
| Jun 26, 2018 | 78 | Entry of appearance for Mark J. Scott as of counsel for Inventia Healthcare Pvt. Ltd. and Mylan Inc.. Service: 06/26/2018 by email. [532040] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 02:29 PM] (2) |
| Jun 26, 2018 | 77 | Entry of appearance for Constantine Koutsoubas as of counsel for Inventia Healthcare Pvt. Ltd. and Mylan Inc.. Service: 06/26/2018 by email. [532033] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 02:27 PM] (2) |
| Jun 26, 2018 | 76 | Entry of appearance for Douglass C. Hochstetler as principal counsel for Inventia Healthcare Pvt. Ltd. and Mylan Inc.. Service: 06/26/2018 by email. [532029] [16-2707] [Douglass Hochstetler] [Entered: 06/26/2018 02:25 PM] (2) |
| Jun 14, 2018 | 75 | 18 paper copies of the petition for en banc rehearing [74] received from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. [529504] [JAB] [Entered: 06/14/2018 03:21 PM] (0) |
| Jun 12, 2018 | 74 | Petition for en banc rehearing filed by Appellants West-Ward Pharmaceuticals International Limited and West-Ward Pharmaceuticals Corp.. Service: 06/12/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 06/14/2018 [528876] [16-2707] [Kenneth Schuler] [Entered: 06/12/2018 04:50 PM] (77) |
| May 3, 2018 | 73 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [72] filed by Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. Petition for Rehearing due on or before 06/12/2018. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [518838] [JAB] [Entered: 05/03/2018 01:43 PM] (2) |
| May 2, 2018 | 72 | MOTION of Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited to extend the time to file a Petition for Rehearing En Banc until 06/12/2018. [Consent: unopposed]. Service: 05/02/2018 by email. [518641] [16-2707] [Kenneth Schuler] [Entered: 05/02/2018 07:35 PM] (11) |
| May 2, 2018 | 71 | Certificate of Interest for the Appellant West-Ward Pharmaceuticals International Limited. Service: 05/02/2018 by email. [518640] [16-2707] [Kenneth Schuler] [Entered: 05/02/2018 07:27 PM] (4) |
| May 2, 2018 | 70 | Certificate of Interest for the Appellant West-Ward Pharmaceuticals Corp.. Service: 05/02/2018 by email. [518639] [16-2707] [Kenneth Schuler] [Entered: 05/02/2018 07:24 PM] (4) |
| Apr 13, 2018 | 69 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Prost, Chief Judge; Lourie, Circuit Judge and Hughes, Circuit Judge). Dissenting opinion filed by Chief Judge Prost. [513126] [16-2707, 16-2708] [JAB] [Entered: 04/13/2018 09:24 AM] (50) |
| Dec 5, 2017 | 68 | Submitted after ORAL ARGUMENT by Kenneth G. Schuler for West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited and Nicholas P. Groombridge for Vanda Pharmaceuticals Inc. Panel: Judge: Prost , Judge: Lourie , Judge: Hughes. [480236] [JCP] [Entered: 12/05/2017 10:28 AM] (0) |
| Nov 29, 2017 | 67 | Sealed or confidential document received [Confidential Letter In Response to the Court's Letter dated November 16, 2017] (corresponding to Doc No. [66]) for Appellee Vanda Pharmaceuticals Inc.. Service: 11/29/2017 by email. [479117] [Nicholas Groombridge] [Entered: 11/29/2017 08:12 PM] (0) |
| Nov 29, 2017 | 66 | Letter from Appellee Vanda Pharmaceuticals Inc. In Response to the Court's Letter dated November 16, 2017. Service: 11/29/2017 by email. [479116] [Nicholas Groombridge] [Entered: 11/29/2017 08:05 PM] (62) |
| Nov 29, 2017 | 65 | Letter from Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited in Response to Court's Letter of November 16, 2017. Service: 11/29/2017 by email. [479109] [Kenneth Schuler] [Entered: 11/29/2017 06:04 PM] (9) |
| Nov 16, 2017 | 64 | Clerk's Letter to Appellants West-Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International Limited and Appellee Vanda Pharmaceuticals Inc. Service as of this date by Clerk of Court. Response due on or before 11/29/2017. [476043] [JAB] [Entered: 11/16/2017 08:43 AM] (2) |
| Oct 23, 2017 | 63 | Response to oral argument order from the Appellee Vanda Pharmaceuticals Inc.. designating Nicholas Groombridge as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [469768] [Nicholas Groombridge] [Entered: 10/23/2017 11:30 AM] (0) |
| Oct 20, 2017 | 62 | Response to oral argument order from the Appellants West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited. designating Kenneth Schuler as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [469585] [Kenneth Schuler] [Entered: 10/20/2017 04:52 PM] (0) |
| Oct 20, 2017 | 61 | NOTICE OF CALENDARING. Panel: 1712E. Case scheduled Dec 05, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 11/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [469384] [JAB] [Entered: 10/20/2017 12:09 PM] (0) |
| Aug 28, 2017 | 60 | Notice from Appellee Vanda Pharmaceuticals Inc. regarding conflicts with oral argument (Oral argument be not set for December 6-8). Service: 08/28/2017 by email. [457084] [Nicholas Groombridge] [Entered: 08/28/2017 02:09 PM] (3) |
| Aug 1, 2017 | 59 | Notice from Appellants West-Ward Pharmaceuticals Corp. and West-ward Pharmaceuticals International Limited regarding conflicts with oral argument (Unavailable October 2-6, 2017). Service: 08/01/2017 by email. [450766] [Kenneth Schuler] [Entered: 08/01/2017 04:57 PM] (1) |
| Aug 1, 2017 | 58 | Certificate of Interest for the Appellant West-ward Pharmaceuticals International Limited. Service: 08/01/2017 by email. [450626] [Kenneth Schuler] [Entered: 08/01/2017 11:21 AM] (3) |
| Aug 1, 2017 | 57 | Certificate of Interest for the Appellant West-Ward Pharmaceuticals Corp.. Service: 08/01/2017 by email. [450624] [Kenneth Schuler] [Entered: 08/01/2017 11:19 AM] (3) |
| Aug 1, 2017 | 56 | Entry of appearance for Robert J. Gajarsa as of counsel for Appellants West-Ward Pharmaceuticals Corp. and West-ward Pharmaceuticals International Limited. Service: 08/01/2017 by email. [450621] [Robert Gajarsa] [Entered: 08/01/2017 11:13 AM] (3) |
| Aug 1, 2017 | 55 | Entry of appearance for Daniel G. Brown as of counsel for Appellants West-Ward Pharmaceuticals Corp. and West-ward Pharmaceuticals International Limited. Service: 08/01/2017 by email. [450618] [Daniel Brown] [Entered: 08/01/2017 11:09 AM] (3) |
| Aug 1, 2017 | 54 | Entry of appearance for Kenneth G. Schuler as principal counsel for Appellants West-Ward Pharmaceuticals Corp. and West-ward Pharmaceuticals International Limited. Service: 08/01/2017 by email. [450613] [Kenneth Schuler] [Entered: 08/01/2017 11:04 AM] (3) |
| Jul 28, 2017 | 53 | ORDER filed. The motion to substitute party [51] is granted. The revised official caption and short caption are reflected in the order.; A copy of this order and the motion shall be transmitted to the merits panel assigned to these appeals, to inform the panel of the substitution and caption change. Service: 07/28/2017 by clerk. [450188] [NL] [Entered: 07/28/2017 04:54 PM] (2) |
| Jul 27, 2017 | 51 | MOTION of Appellant Roxane Laboratories Inc. to substitute party. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/27/2017 by email. [449735] [Kenneth Schuler] [Entered: 07/27/2017 01:55 PM] (11) |
| Jul 17, 2017 | 50 | Notice from Appellee Vanda Pharmaceuticals Inc. regarding conflicts with oral argument (Oral argument not be set for November 6-9). Service: 07/17/2017 by email. [447139] [Nicholas Groombridge] [Entered: 07/17/2017 04:41 PM] (3) |
| Jun 14, 2017 | 49 | Notice from Appellee Vanda Pharmaceuticals Inc. regarding conflicts with oral argument (Oral argument be not set for September 5, 2017). Service: 06/14/2017 by email. [439240] [Nicholas Groombridge] [Entered: 06/14/2017 03:09 PM] (3) |
| May 16, 2017 | 48 | Notice from Appellee Vanda Pharmaceuticals Inc. regarding conflicts with oral argument (Oral argument not be set for July 10-14, August 8-9, and September 6-8.). Service: 05/16/2017 by email. [431888] [Nicholas Groombridge] [Entered: 05/16/2017 01:01 PM] (3) |
| May 12, 2017 | 47 | Notice from Appellant Roxane Laboratories Inc. regarding conflicts with oral argument (unavailable for argument August 7-11). Service: 05/12/2017 by email. [431190] [Kenneth Schuler] [Entered: 05/12/2017 06:28 PM] (1) |
| May 12, 2017 | 46 | 6 paper copies of the Confidential Joint Appendix in 2 Volumes [43] received from Appellant Roxane Laboratories Inc. [431141] [JCP] [Entered: 05/12/2017 03:52 PM] (0) |
| May 11, 2017 | 45 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks (July 2017, August 2017, September 2017), or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 05/18/2017. [430514] [JCA] [Entered: 05/11/2017 09:47 AM] (0) |
| May 10, 2017 | 44 | APPENDIX FILED for Roxane Laboratories Inc. [42]. Number of Pages: 706. Service: 05/10/2017 by email. [430508] [JCA] [Entered: 05/11/2017 09:41 AM] (706) |
| May 10, 2017 | 43 | CONFIDENTIAL JOINT APPENDIX FILED for Roxane Laboratories Inc. [41]. Number of Pages: 788. Service: 05/10/2017 by email. The paper copies of the confidential appendix should be received by the court on or before 05/18/2017. [430505] [JCA] [Entered: 05/11/2017 09:37 AM] (0) |
| May 10, 2017 | 42 | TENDERED from Appellant Roxane Laboratories Inc.. Title: JOINT APPENDIX. Service: 05/10/2017 by email. [430466] [Kenneth Schuler] [Entered: 05/10/2017 10:06 PM] (706) |
| May 10, 2017 | 41 | TENDERED from Appellant Roxane Laboratories Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/10/2017 by email. [430465] [Kenneth Schuler] [Entered: 05/10/2017 10:02 PM] (0) |
| May 10, 2017 | 40 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Roxane Laboratories Inc. and Appellee Vanda Pharmaceuticals Inc.. Service: 05/10/2017 by email. [430458] [Kenneth Schuler] [Entered: 05/10/2017 05:51 PM] (4) |
| May 10, 2017 | 39 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Roxane Laboratories Inc. and Appellee Vanda Pharmaceuticals Inc.. Service: 05/10/2017 by email. [430455] [Kenneth Schuler] [Entered: 05/10/2017 05:44 PM] (4) |
| May 5, 2017 | 38 | 6 paper copies of the Reply Brief [37] received from Appellant Roxane Laboratories Inc. [429442] [JCP] [Entered: 05/05/2017 03:07 PM] (0) |
| May 3, 2017 | 37 | REPLY BRIEF FILED for Appellant Roxane Laboratories Inc. [36]. Number of Pages: 34. Service: 05/03/2017 by email. The paper copies of the brief should be received by the court on or before 05/11/2017. Appendix is due 05/10/2017. [429030] [JCA] [Entered: 05/04/2017 08:43 AM] (44) |
| May 3, 2017 | 36 | TENDERED from Appellant Roxane Laboratories Inc.. Title: REPLY BRIEF. Service: 05/03/2017 by email. [429012] [Kenneth Schuler] [Entered: 05/03/2017 08:03 PM] (44) |
| Apr 21, 2017 | 35 | **TEXT ONLY** ORDER granting motion to withdraw attorney Melissa A. Brand [34] filed by Appellant Roxane Laboratories Inc.. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [426300] [JCA] [Entered: 04/21/2017 03:35 PM] (0) |
| Apr 21, 2017 | 34 | MOTION of Appellant Roxane Laboratories Inc. to withdraw counsel Melissa A. Brand. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/21/2017 by email. [426297] [Kenneth Schuler] [Entered: 04/21/2017 03:30 PM] (5) |
| Apr 21, 2017 | 33 | 6 paper copies of the Response Brief [29] received from Appellee Vanda Pharmaceuticals Inc. [426251] [KW] [Entered: 04/21/2017 02:52 PM] (0) |
| Apr 21, 2017 | 32 | **TEXT ONLY** ORDER granting motion to withdraw attorney Emily C. Melvin [31] filed by Appellant Roxane Laboratories Inc.. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [426145] [JCA] [Entered: 04/21/2017 12:20 PM] (0) |
| Apr 21, 2017 | 31 | MOTION of Appellant Roxane Laboratories Inc. to withdraw counsel Emily C. Melvin. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/21/2017 by email. [426138] [Kenneth Schuler] [Entered: 04/21/2017 12:15 PM] (5) |
| Apr 20, 2017 | 30 | ORDER filed. The motion [27] is granted to the extent that the revised official caption is reflected in the order. Service: 04/20/2017 by clerk. [425854] [LMS] [Entered: 04/20/2017 01:40 PM] (2) |
| Apr 19, 2017 | 29 | BRIEF FILED for Appellee Vanda Pharmaceuticals Inc. [28]. Number of Pages: 65. Service: 04/19/2017 by email. The paper copies of the brief should be received by the court on or before 04/27/2017. Appellant Roxane Laboratories Inc. reply brief is due 05/03/2017. [425724] [JCA] [Entered: 04/20/2017 08:58 AM] (78) |
| Apr 19, 2017 | 28 | TENDERED from Appellee Vanda Pharmaceuticals Inc.. Title: RESPONSE BRIEF. Service: 04/19/2017 by email. [425680] [Nicholas Groombridge] [Entered: 04/19/2017 05:32 PM] (78) |
| Apr 18, 2017 | 27 | MOTION of Appellee Aventisub LLC to modify the official caption. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/18/2017 by email. [425111] [Nicholas Groombridge] [Entered: 04/18/2017 01:40 PM] (8) |
| Feb 9, 2017 | 26 | 6 paper copies of the Confidential Opening Brief [24] received from Appellant Roxane Laboratories Inc. [406046] [KW] [Entered: 02/09/2017 02:13 PM] (0) |
| Feb 7, 2017 | 25 | BRIEF FILED for Appellant Roxane Laboratories Inc. [23]. Number of Pages: 65. Service: 02/07/2017 by email. Appellees Aventisub LLC and Vanda Pharmaceuticals Inc. brief is due 04/19/2017. [405550] [JCA] [Entered: 02/08/2017 10:43 AM] (127) |
| Feb 7, 2017 | 24 | CONFIDENTIAL BRIEF FILED for Appellant Roxane Laboratories Inc. [22]. Number of Pages: 65. Service: 02/07/2017 by email. The paper copies of the brief should be received by the court on or before 02/15/2017. [405549] [JCA] [Entered: 02/08/2017 10:37 AM] (0) |
| Feb 7, 2017 | 23 | TENDERED from Appellant Roxane Laboratories Inc.. Title: OPENING BRIEF. Service: 02/07/2017 by email. [405454] [Kenneth Schuler] [Entered: 02/07/2017 08:09 PM] (127) |
| Feb 7, 2017 | 22 | TENDERED from Appellant Roxane Laboratories Inc.. Title: CONFIDENTIAL OPENING BRIEF Service: 02/07/2017 by email. [405453] [Kenneth Schuler] [Entered: 02/07/2017 08:07 PM] (0) |
| Jan 12, 2017 | 21 | ORDER filed. The motion [20] is granted. The appellant's principal brief is due February 7, 2017, and the appellees' response brief is due April 19, 2017. Service: 01/12/2017 by clerk. [398354] [LMS] [Entered: 01/12/2017 03:28 PM] (2) |
| Jan 11, 2017 | 20 | MOTION of Appellant Roxane Laboratories Inc. to extend the time to 02/07/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/11/2017 by email. [397883] [Kenneth Schuler] [Entered: 01/11/2017 01:46 PM] (6) |
| Dec 15, 2016 | 19 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [391528] [JCA] [Entered: 12/15/2016 03:41 PM] (0) |
| Oct 14, 2016 | 18 | ORDER filed. The motion [17] is granted to the extent that Roxane's opening brief is due no later than January 24, 2017 and Vanda's response brief is due no later than April 5, 2017. Service: 10/14/2016 by clerk. [374105] [LMS] [Entered: 10/14/2016 09:25 AM] (2) |
| Oct 12, 2016 | 17 | MOTION of Appellant Roxane Laboratories Inc. and Appellees Aventisub LLC and Vanda Pharmaceuticals Inc. to extend the time to 01/24/2017 to file the appellant/petitioner's principal brief. Response/Opposition is due 10/27/2016, to extend the time to 04/05/2017 to file the appellee/respondent/cross-appellant's principal brief. [Consent: unopposed]. Service: 10/12/2016 by email. [373430] [Kenneth Schuler] [Entered: 10/12/2016 10:50 AM] (12) |
| Oct 12, 2016 | 16 | Entry of appearance for Melissa A. Brand as of counsel for Appellant Roxane Laboratories Inc.. Service: 10/12/2016 by email. [373387] [Melissa Brand] [Entered: 10/12/2016 09:51 AM] (3) |
| Oct 11, 2016 | 15 | Entry of appearance for Emily C. Melvin as of counsel for Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373294] [Emily Melvin] [Entered: 10/11/2016 05:42 PM] (3) |
| Oct 11, 2016 | 14 | Entry of appearance for Robert J. Gajarsa as of counsel for Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373290] [Robert Gajarsa] [Entered: 10/11/2016 05:34 PM] (3) |
| Oct 11, 2016 | 13 | Entry of appearance for Daniel G. Brown as of counsel for Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373286] [Daniel Brown] [Entered: 10/11/2016 05:29 PM] (3) |
| Oct 11, 2016 | 12 | Docketing Statement for the Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373283] [Kenneth Schuler] [Entered: 10/11/2016 05:24 PM] (4) |
| Oct 11, 2016 | 11 | Certificate of Interest for the Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373281] [Kenneth Schuler] [Entered: 10/11/2016 05:22 PM] (3) |
| Oct 11, 2016 | 10 | Entry of appearance for Kenneth G. Schuler as principal counsel for Appellant Roxane Laboratories Inc.. Service: 10/11/2016 by email. [373279] [Kenneth Schuler] [Entered: 10/11/2016 05:20 PM] (3) |
| Oct 11, 2016 | 9 | Certificate of Interest for the Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373277] [Nicholas Groombridge] [Entered: 10/11/2016 05:18 PM] (3) |
| Oct 11, 2016 | 8 | Docketing Statement for the Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373276] [Nicholas Groombridge] [Entered: 10/11/2016 05:16 PM] (5) |
| Oct 11, 2016 | 7 | Entry of appearance for Josephine Young as of counsel for Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373273] [Nicholas Groombridge] [Entered: 10/11/2016 05:15 PM] (2) |
| Oct 11, 2016 | 6 | Entry of appearance for Eric A. Stone as of counsel for Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373270] [Nicholas Groombridge] [Entered: 10/11/2016 05:13 PM] (2) |
| Oct 11, 2016 | 5 | Entry of appearance for Daniel J. Klein as of counsel for Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373267] [Nicholas Groombridge] [Entered: 10/11/2016 05:11 PM] (2) |
| Oct 11, 2016 | 4 | Entry of appearance for Kira A. Davis as of counsel for Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373264] [Nicholas Groombridge] [Entered: 10/11/2016 05:10 PM] (2) |
| Oct 11, 2016 | 3 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellees Aventisub LLC and Vanda Pharmaceuticals Inc.. Service: 10/11/2016 by email. [373263] [Nicholas Groombridge] [Entered: 10/11/2016 05:08 PM] (2) |
| Sep 26, 2016 | 2 | Note to file: The following cases are associated:16-2707 Lead with 16-2708 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [369303] [16-2707, 16-2708] [JCA] [Entered: 09/26/2016 03:41 PM] (0) |
| Sep 26, 2016 | 1 | Appeal docketed. Received: 09/26/2016. [369297]Entry of Appearance due 10/11/2016. Certificate of Interest is due on 10/11/2016. Docketing Statement due 10/11/2016. Appellant/Petitioner's brief is due 11/25/2016. [JCA] [Entered: 09/26/2016 03:32 PM] (28) |
